Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer.
Eichbaum M, Mayer C, Eickhoff R, Bischofs E, Gebauer G, Fehm T, Lenz F, Fricke HC, Solomayer E, Fersis N, Schmidt M, Wallwiener M, Schneeweiss A, Sohn C. Eichbaum M, et al. Among authors: eickhoff r. BMC Cancer. 2011 Oct 20;11:453. doi: 10.1186/1471-2407-11-453. BMC Cancer. 2011. PMID: 22014006 Free PMC article. Clinical Trial.
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial.
Christopoulos P, Bozorgmehr F, Brückner L, Chung I, Krisam J, Schneider MA, Stenzinger A, Eickhoff R, Mueller DW, Thomas M. Christopoulos P, et al. Among authors: eickhoff r. BMC Cancer. 2021 Jun 28;21(1):743. doi: 10.1186/s12885-021-08460-w. BMC Cancer. 2021. PMID: 34182952 Free PMC article. Clinical Trial.
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC.
Kroh A, Walter J, Fragoulis A, Möckel D, Lammers T, Kiessling F, Andruszkow J, Preisinger C, Egbert M, Jiao L, Eickhoff RM, Heise D, Berndt N, Cramer T, Neumann UP, Egners A, Ulmer TF. Kroh A, et al. Among authors: eickhoff rm. Neoplasia. 2023 Dec;46:100945. doi: 10.1016/j.neo.2023.100945. Epub 2023 Nov 15. Neoplasia. 2023. PMID: 37976569 Free PMC article.
A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology.
Al-Batran SE, Mueller DW, Rafiyan MR, Kiselicki D, Atmaca A, Habibzada T, Mueller C, Brignone C, Triebel F, Loose M, Schaaf M, Sookthai D, Eickhoff R, Jaeger E, Goetze TO. Al-Batran SE, et al. Among authors: eickhoff r. ESMO Open. 2023 Oct;8(5):101623. doi: 10.1016/j.esmoop.2023.101623. Epub 2023 Sep 22. ESMO Open. 2023. PMID: 37742484 Free PMC article. Clinical Trial.
The impact of the COVID-19 outbreak on emergency general surgery in the first German "hotspot region" Aachen-Heinsberg-A multicentre retrospective cohort study.
Chrysos A, Amygdalos I, Nunes P, Haselow G, Lioupis K, Rosch R, Eickhoff RM, Wiltberger G, Neumann UP, Lambertz A. Chrysos A, et al. Among authors: eickhoff rm. PLoS One. 2023 Jan 25;18(1):e0280867. doi: 10.1371/journal.pone.0280867. eCollection 2023. PLoS One. 2023. PMID: 36696422 Free PMC article.
No difference in outcomes between large- and small-pore meshes in a prospective, randomized, multicenter trial investigating open retromuscular meshplasty for incisional hernia repair.
Kroh A, Zufacher M, Eickhoff R, Heise D, Helmedag M, Ulmer F, Neumann UP, Conze J, Hilgers RD, Binnebösel M. Kroh A, et al. Among authors: eickhoff r. Langenbecks Arch Surg. 2023 Jan 13;408(1):22. doi: 10.1007/s00423-022-02751-x. Langenbecks Arch Surg. 2023. PMID: 36635466 Free PMC article. Clinical Trial.
57 results